Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial

Article

publication date

  • April 1, 2022

webpage

published in

keywords

  • & nbsp;IL-5 receptor
  • & nbsp;biologic
  • & nbsp;eosinophilia
  • & nbsp;intranasal corticosteroids
  • & nbsp;nasal blockage
  • & nbsp;sinonasal polyposis
  • & nbsp;type 2 inflammation

  • & nbsp;nasal polyposis

  • & nbsp;systemic corticosteroids

  • Eosinophils

start page

  • 1309

end page

  • +

volume

  • 149

issue

  • 4